Unichem Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE351A01035
  • NSEID: UNICHEMLAB
  • BSEID: 506690
INR
440.00
-6.1 (-1.37%)
BSENSE

Jun 15, 03:30 PM

BSE+NSE Vol: 6.53 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
RPG LifeScience.
Novartis India
Gufic BioScience
SMS Pharma.
Morepen Labs.
Aarti Drugs
Panacea Biotec
Solara Active
Unichem Labs.
Dishman Carbogen
Sai Parenteral's

Why is Unichem Laboratories Ltd ?

1
Negative results in Mar 26
  • PBT LESS OI(Q) At Rs 7.68 cr has Fallen at -52.9% (vs previous 4Q average)
  • PAT(Q) At Rs 18.09 cr has Fallen at -31.1% (vs previous 4Q average)
  • DEBTORS TURNOVER RATIO(HY) Lowest at 2.66 times
2
Underperformed the market in the last 1 year
  • Even though the market (BSE500) generated negative returns of -0.51% in the last 1 year, its fall in the stock was much higher with a return of -27.75%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Unichem Labs. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Unichem Labs.
-27.75%
-0.68
40.81%
Sensex
-5.98%
-0.45
13.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.26%
EBIT Growth (5y)
52.68%
EBIT to Interest (avg)
-0.96
Debt to EBITDA (avg)
4.81
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.59
Tax Ratio
13.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
11.63%
ROCE (avg)
-0.23%
ROE (avg)
1.89%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
44
Industry P/E
34
Price to Book Value
1.14
EV to EBIT
59.11
EV to EBITDA
18.28
EV to Capital Employed
1.13
EV to Sales
1.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.92%
ROE (Latest)
2.58%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 294.70 cr

-20What is not working for the Company
PBT LESS OI(Q)

At Rs 7.68 cr has Fallen at -52.9% (vs previous 4Q average

PAT(Q)

At Rs 18.09 cr has Fallen at -31.1% (vs previous 4Q average

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.66 times

INTEREST(Q)

Highest at Rs 9.39 cr

NON-OPERATING INCOME(Q)

is 75.35 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for Unichem Labs.

Cash and Cash Equivalents - Half Yearly
Highest at Rs 294.70 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Unichem Labs.

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 7.68 cr has Fallen at -52.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 16.32 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 18.09 cr has Fallen at -31.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 26.25 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Quarterly
At Rs 9.39 cr has Grown at 26.55%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 9.39 cr
in the last five quarters and Increased by 26.55 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Non Operating Income - Quarterly
is 75.35 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Debtors Turnover Ratio- Half Yearly
Lowest at 2.66 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio

Non Operating Income - Quarterly
Highest at Rs 23.47 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income